< Back to previous page
Researcher
Charlien Berghen
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Radiotherapy (Division)
Member
From1 Aug 2017 → 11 Oct 2021
Projects
1 - 1 of 1
- Traveling the prostate cancer timeline in chase of treatment paradigms Can we cure the incurable?From1 Aug 2017 → 1 Oct 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 47
- Moderate hypofractionated radiotherapy for prostate cancer: 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial.(2024)
Authors: Charlien Berghen, Gert De Meerleer
Pages: 110089 - Salvage vesiculectomy for local prostate cancer recurrence: surgical technique and early post-operative outcomes(2024)
Authors: Alexander Giesen, Kato Rans, Charlien Berghen, Steven Joniau
- The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects(2023)
Authors: Steven Joniau, Charlien Berghen, Kato Rans, Gert De Meerleer
- Predictors of Recurrence After Metastasis-directed Therapy in Oligorecurrent Prostate Cancer Following Radical Prostatectomy(2023)
Authors: Charlien Berghen, Steven Joniau, Gert De Meerleer
Pages: 582 - 589 - ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer(2023)
Authors: Gaëtan Devos, Marcella Baldewijns, Karolien Goffin, Annouschka Laenen, Gert De Meerleer, Charlien Berghen, Frank Claessens, Hendrik Van Poppel, Wouter Everaerts, Steven Joniau
- Evaluating the Impact of Prostate Only Versus Pelvic Radiotherapy for Pathological Node-positive Prostate Cancer: First Results from the Multicenter Phase 3 PROPER Trial(2023)
Authors: Charlien Berghen, Gert De Meerleer
Pages: 317 - 324 - Dosimetric and Hematologic Implications of Prostate-Only Versus Whole Pelvic Radiotherapy: Results of the Multicentric Phase 3 PROPER Study(2023)
Authors: Charlien Berghen, Kato Rans
- Defining the optimal template of salvage lymph node dissection for unilateral pelvic nodal recurrence of prostate cancer following radical prostatectomy(2023)
Authors: Gaëtan Devos, Charlien Berghen, Wouter Everaerts, Gert De Meerleer, Steven Joniau
Pages: 92 - 99 - Adjuvant Radiotherapy After Radical Cystectomy for Patients with High-risk Muscle-invasive Bladder Cancer: Results of a Multicentric Phase II Trial(2022)
Authors: Charlien Berghen, Gert De Meerleer
Pages: 1238 - 1245 - Another Step Towards the Acceptance of Metastasis-directed Therapy in Low-volume Metastatic Prostate Cancer(2022)
Authors: Gert De Meerleer, Kato Rans, Steven Joniau, Charlien Berghen
Pages: 428 - 429